IgG Subclass Switch in Volunteers Repeatedly Immunized with the Full-Length <i>Plasmodium falciparum</i> Merozoite Surface Protein 1 (MSP1)

IgG Subclass Switch in Volunteers Repeatedly Immunized with the Full-Length <i>Plasmodium falciparum</i> Merozoite Surface Protein 1 (MSP1)

Vaccines are highly effective tools against infectious diseases and are also considered necessary in the fight against malaria. Vaccine-induced immunity is frequently mediated by antibodies. We have recently conducted a first-in-human clinical trial featuring SumayaVac-1, a malaria vaccine based on...

Full description

Bibliographic Details
Main Authors: Veronika Rathay, Kristin Fürle, Viktoria Kiehl, Anne Ulmer, Michael Lanzer, Richard Thomson-Luque
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Vaccines
Subjects:
malaria
vaccines
<i>Plasmodium falciparum</i>
MSP1
IgG subclass
Online Access:https://www.mdpi.com/2076-393X/12/2/208

Similar Items

Similar Items